Strides Pharma Science Limited (NSE:STAR)
857.95
+0.30 (0.03%)
Feb 16, 2026, 11:30 AM IST
Strides Pharma Science Market Cap
Strides Pharma Science has a market cap or net worth of 79.05 billion as of February 13, 2026. Its market cap has increased by 48.60% in one year.
Market Cap
79.05B
Enterprise Value
95.68B
Revenue
47.26B
Ranking
n/a
PE Ratio
15.46
Stock Price
857.95
Market Cap Chart
Since February 2, 2000, Strides Pharma Science's market cap has increased from 7.49B to 79.05B, an increase of 954.87%. That is a compound annual growth rate of 9.47%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 13, 2026 | 79.05B | -4.74% |
| Dec 31, 2025 | 82.99B | 36.56% |
| Dec 31, 2024 | 60.77B | 1.87% |
| Dec 29, 2023 | 59.66B | 88.83% |
| Dec 30, 2022 | 31.59B | -21.29% |
| Dec 31, 2021 | 40.14B | -49.01% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eris Lifesciences | 195.93B |
| Alembic Pharmaceuticals | 151.33B |
| NATCO Pharma | 147.56B |
| Cohance Lifesciences | 120.74B |
| Alivus Life Sciences | 112.89B |
| Akums Drugs and Pharmaceuticals | 69.10B |
| Aarti Pharmalabs | 64.29B |
| Sun Pharma Advanced Research Company | 42.87B |